Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gall, M. A.
Right arrow Articles by Parving, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gall, M. A.
Right arrow Articles by Parving, H. H.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 44, Issue 11 1303-1309, Copyright © 1995 by American Diabetes Association

ARTICLES

Albuminuria and poor glycemic control predict mortality in NIDDM

MA Gall, K Borch-Johnsen, P Hougaard, FS Nielsen and HH Parving
Steno Diabetes Center, Gentofte, Denmark.

The impact of microalbuminuria and macroalbuminuria on mortality was evaluated prospectively in 328 Caucasian patients with non-insulin-dependent diabetes mellitus (NIDDM) followed for 5 years. One hundred ninety-one (109 men and 82 women) patients with normoalbuminuria (albumin excretion rate [AER] < 30 mg/24 h), 86 (50 men and 36 women) patients with microalbuminuria (AER 30-299 mg/24 h), and 51 (43 men and 8 women) patients with macroalbuminuria (AER > or = 300 mg/24 h) < 66 years old at entry were followed from 1987 until death or until 1 January 1993. Mean age at entry was 54 (SD 9) years. In January 1993, 8% of patients with normoalbuminuria, 20% of patients with microalbuminuria, and 35% of patients with macroalbuminuria had died (predominantly from cardiovascular disease) (P < 0.01 [normoalbuminuria versus micro- and macroalbuminuria] and P < 0.05 [microalbuminuria versus macroalbuminuria]). Cox multiple regression analysis revealed significant predictors of all-cause mortality to be preexisting coronary heart disease (relative risk [95% confidence interval]), 2.9 (1.6-5.1); log10AER (factor 10), 1.9 (1.4-2.6); HbA1c level (%), 1.2 (1.0-1.4); and age (years), 1.08 (1.03-1.13). Significant predictors of cardiovascular mortality included preexisting coronary heart disease, 6.1 (2.8-13.5); macroalbuminuria, 2.5 (1.1-5.8); HbA1c level (%), 1.3 (1.1-1.6); and systolic blood pressure (10 mmHg), 1.2 (1.0-1.4). Univariate Cox survival analysis in the normoalbuminuric group revealed that AER above the median of 8 mg/24 h was associated with an increased all-cause mortality risk of 2.7 (0.93-7.69) (P = 0.07).(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
J. Han, A. E. Woytowich, A. K. Mandal, and L. M. Hiebert
Heparanase Upregulation in High Glucose-Treated Endothelial Cells Is Prevented by Insulin and Heparin
Experimental Biology and Medicine, July 1, 2007; 232(7): 927 - 934.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
F. Persson, P. Rossing, P. Hovind, C. D.A. Stehouwer, C. Schalkwijk, L. Tarnow, and H.-H. Parving
Irbesartan Treatment Reduces Biomarkers of Inflammatory Activity in Patients With Type 2 Diabetes and Microalbuminuria: An IRMA 2 Substudy
Diabetes, December 1, 2006; 55(12): 3550 - 3555.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
N. Nobakhthaghighi, M. Kamgar, M. R. Bekheirnia, K. McFann, R. Estacio, and R. W. Schrier
Relationship between Urinary Albumin Excretion and Left Ventricular Mass with Mortality in Patients with Type 2 Diabetes
Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1187 - 1190.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. Pietroiusti, M. Giuliano, A. Magrini, A. Bergamaschi, and A. Galante
Cytotoxin-Associated Gene A Strains of Helicobacter Pylori Represent a Risk Factor for the Development of Microalbuminuria in Type 2 Diabetes.
Diabetes Care, June 1, 2006; 29(6): 1399 - 1401.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
J. R. Madison, C. Spies, I. J. Schatz, K. Masaki, R. Chen, K. Yano, and J. D. Curb
Proteinuria and Risk for Stroke and Coronary Heart Disease During 27 Years of Follow-up: The Honolulu Heart Program.
Arch Intern Med, April 24, 2006; 166(8): 884 - 889.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
G. F.M. Strippoli, M. Craig, F. P. Schena, and J. C. Craig
Antihypertensive Agents for Primary Prevention of Diabetic Nephropathy
J. Am. Soc. Nephrol., October 1, 2005; 16(10): 3081 - 3091.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. S. Jensen, B. Feldt-Rasmussen, K. Borch-Johnsen, K. S. Jensen, and B. G. Nordestgaard
Increased Transvascular Lipoprotein Transport in Diabetes: Association with Albuminuria and Systolic Hypertension
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4441 - 4445.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
C. Briguori, G. Condorelli, F. Airoldi, F. Manganelli, A. Violante, A. Focaccio, B. Ricciardelli, and A. Colombo
Impact of microvascular complications on outcome after coronary stent implantations in patients with diabetes
J. Am. Coll. Cardiol., February 1, 2005; 45(3): 464 - 466.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
A. Juutilainen, S. Kortelainen, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso
Gender Difference in the Impact of Type 2 Diabetes on Coronary Heart Disease Risk
Diabetes Care, December 1, 2004; 27(12): 2898 - 2904.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
F. W. Asselbergs, G. F.H. Diercks, H. L. Hillege, A. J. van Boven, W. M.T. Janssen, A. A. Voors, D. de Zeeuw, P. E. de Jong, D. J. van Veldhuisen, W. H. van Gilst, et al.
Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria
Circulation, November 2, 2004; 110(18): 2809 - 2816.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
C. Kragelund, O. Snorgaard, L. Kober, B. Bengtsson, M. Ottesen, S. Hojberg, C. Olesen, J.-J. Kjaergaard, J. Carlsen, C. Torp-Petersen, et al.
Hyperinsulinaemia is associated with increased long-term mortality following acute myocardial infarction in non-diabetic patients
Eur. Heart J., November 1, 2004; 25(21): 1891 - 1897.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, F. L. Brancati, N. R. Powe, and S. H. Golden
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
Ann Intern Med, September 21, 2004; 141(6): 421 - 431.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
T. S. Polhill, S. Saad, P. Poronnik, G. R. Fulcher, and C. A. Pollock
Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure
Am J Physiol Renal Physiol, August 1, 2004; 287(2): F268 - F273.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K. Klausen, K. Borch-Johnsen, B. Feldt-Rasmussen, G. Jensen, P. Clausen, H. Scharling, M. Appleyard, and J. S. Jensen
Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes
Circulation, July 6, 2004; 110(1): 32 - 35.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
G. F. Salles, K. V. Bloch, and C. R.L. Cardoso
Mortality and Predictors of Mortality in a Cohort of Brazilian Type 2 Diabetic Patients
Diabetes Care, June 1, 2004; 27(6): 1299 - 1305.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al.
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Hypertension, November 1, 2003; 42(5): 1050 - 1065.
[Full Text] [PDF]

Home page
 CirculationHome page
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al.
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Circulation, October 28, 2003; 108(17): 2154 - 2169.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Matsagoura, E. Andreadis, E. J. Diamantopoulos, C. Vassilopoulos, N. Tentolouris, and N. Katsilambros
Carotid Intima-Media Thickness in Patients With Type 2 Diabetes: The significance of microalbuminuria and different risk factors for atherosclerosis
Diabetes Care, October 1, 2003; 26(10): 2966 - 2966.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
M. S. Perassolo, J. C. Almeida, R. L. Pra, V. D. Mello, A. L. Maia, C. C. Moulin, J. L. Camargo, T. Zelmanovitz, M. J. Azevedo, and J. L. Gross
Fatty Acid Composition of Serum Lipid Fractions in Type 2 Diabetic Patients With Microalbuminuria
Diabetes Care, March 1, 2003; 26(3): 613 - 618.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. Gaede, P. Vedel, N. Larsen, G. V.H. Jensen, H.-H. Parving, and O. Pedersen
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
N. Engl. J. Med., January 30, 2003; 348(5): 383 - 393.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. R. Sowers and S. Haffner
Treatment of Cardiovascular and Renal Risk Factors in the Diabetic Hypertensive
Hypertension, December 1, 2002; 40(6): 781 - 788.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
G. Viberti, S. E. Kahn, D. A. Greene, W. H. Herman, B. Zinman, R. R. Holman, S. M. Haffner, D. Levy, J. M. Lachin, R. A. Berry, et al.
A Diabetes Outcome Progression Trial (ADOPT): An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes
Diabetes Care, October 1, 2002; 25(10): 1737 - 1743.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. H. Opie and H.-H. Parving
Diabetic Nephropathy: Can Renoprotection Be Extrapolated to Cardiovascular Protection?
Circulation, August 6, 2002; 106(6): 643 - 645.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
P. B. Leurs, R. P. Stolk, K. Hamulyak, R. van Oerle, D. E. Grobbee, and B. H. R. Wolffenbuttel
Tissue Factor Pathway Inhibitor and Other Endothelium-Dependent Hemostatic Factors in Elderly Individuals With Normal or Impaired Glucose Tolerance and Type 2 Diabetes
Diabetes Care, August 1, 2002; 25(8): 1340 - 1345.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
K. Kornerup, B. G. Nordestgaard, B. Feldt-Rasmussen, K. Borch-Johnsen, K. S. Jensen, and J. S. Jensen
Transvascular Low-Density Lipoprotein Transport in Patients With Diabetes Mellitus (Type 2): A Noninvasive In Vivo Isotope Technique
Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1168 - 1174.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
E.B. Jude, S.G. Anderson, J.K. Cruickshank, A. Srivatsa, N. Tentolouris, R. Chandrasekaran, R. Gokal, and A.J.M. Boulton
Natural history and prognostic factors of diabetic nephropathy in type 2 diabetes
QJM, June 1, 2002; 95(6): 371 - 377.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. D.A. Stehouwer, M.-A. Gall, J. W.R. Twisk, E. Knudsen, J. J. Emeis, and H.-H. Parving
Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes: Progressive, Interrelated, and Independently Associated With Risk of Death
Diabetes, April 1, 2002; 51(4): 1157 - 1165.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. J. Caro, A. J. Ward, and J. A. O'Brien
Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S.
Diabetes Care, March 1, 2002; 25(3): 476 - 481.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. M.E. Spoelstra-de Man, C. B. Brouwer, C. D.A. Stehouwer, and Y. M. Smulders
Rapid Progression of Albumin Excretion Is an Independent Predictor of Cardiovascular Mortality in Patients With Type 2 Diabetes and Microalbuminuria
Diabetes Care, December 1, 2001; 24(12): 2097 - 2101.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
T. Morioka, M. Emoto, T. Tabata, T. Shoji, H. Tahara, H. Kishimoto, E. Ishimura, and Y. Nishizawa
Glycemic Control Is a Predictor of Survival for Diabetic Patients on Hemodialysis
Diabetes Care, May 1, 2001; 24(5): 909 - 913.
[Abstract] [Full Text]

Home page
 Nephrol Dial TransplantHome page
A. Jager, V. W. M. van Hinsbergh, P. J. Kostense, J. J. Emeis, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D. A. Stehouwer
Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria
Nephrol. Dial. Transplant., March 1, 2001; 16(3): 529 - 536.
[Abstract] [Full Text] [PDF]

Home page
 Qual Saf Health CareHome page
A Melville, R Richardson, D Lister-Sharp, and A McIntosh
Complications of diabetes: renal disease and promotion of self-management
Qual. Saf. Health Care, December 1, 2000; 9(4): 257 - 263.
[Full Text]

Home page
 Arch Intern MedHome page
C. T. Valmadrid, R. Klein, S. E. Moss, and B. E. K. Klein
The Risk of Cardiovascular Disease Mortality Associated With Microalbuminuria and Gross Proteinuria in Persons With Older-Onset Diabetes Mellitus
Arch Intern Med, April 24, 2000; 160(8): 1093 - 1100.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. S. Jensen, B. Feldt-Rasmussen, S. Strandgaard, M. Schroll, and K. Borch-Johnsen
Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease
Hypertension, April 1, 2000; 35(4): 898 - 903.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
K. Borch-Johnsen, B. Feldt-Rasmussen, S. Strandgaard, M. Schroll, and J. S. Jensen
Urinary Albumin Excretion : An Independent Predictor of Ischemic Heart Disease
Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1992 - 1997.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
B. H. Sung, J. L. Izzo Jr, P. Dandona, and M. F. Wilson
Vasodilatory Effects of Troglitazone Improve Blood Pressure at Rest and During Mental Stress in Type 2 Diabetes Mellitus
Hypertension, July 1, 1999; 34(1): 83 - 88.
[Abstract] [Full Text] [PDF]

Home page
 Vasc MedHome page
S. D. Kanters, J.-D. Banga, R. P Stolk, and A. Algra
Incidence and determinants of mortality and cardiovascular events in diabetes mellitus: a meta-analysis
Vascular Medicine, May 1, 1999; 4(2): 67 - 75.
[Abstract] [PDF]

Home page
 Endocr. Rev.Home page
S. M. Haffner
The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease
Endocr. Rev., October 1, 1998; 19(5): 583 - 592.
[Abstract] [Full Text]

Home page
 BMJHome page
R C Turner, H Millns, H A W Neil, I M Stratton, S E Manley, D R Matthews, and R R Holman
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
BMJ, March 14, 1998; 316(7134): 823 - 828.
[Abstract] [Full Text]

Home page
 Arch Intern MedHome page
B. Gaster and I. B. Hirsch
The Effects of Improved Glycemic Control on Complications in Type 2 Diabetes
Arch Intern Med, January 26, 1998; 158(2): 134 - 140.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Muggeo, G. Verlato, E. Bonora, G. Zoppini, M. Corbellini, and R. de Marco
Long-term Instability of Fasting Plasma Glucose, a Novel Predictor of Cardiovascular Mortality in Elderly Patients With Non–Insulin-Dependent Diabetes Mellitus : The Verona Diabetes Study
Circulation, September 16, 1997; 96(6): 1750 - 1754.
[Abstract] [Full Text]

Home page
 StrokeHome page
L. Mykkanen, D. J. Zaccaro, D. H. O'Leary, G. Howard, D. C. Robbins, and S. M. Haffner
Microalbuminuria and Carotid Artery Intima-Media Thickness in Nondiabetic and NIDDM Subjects : The Insulin Resistance Atherosclerosis Study (IRAS)
Stroke, September 1, 1997; 28(9): 1710 - 1716.
[Abstract] [Full Text]

Home page
 BMJHome page
K. Malmberg
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
BMJ, May 24, 1997; 314(7093): 1512 - 1512.
[Abstract] [Full Text]

Home page
 BMJHome page
M.-A. Gall, P. Hougaard, K. Borch-Johnsen, and H.-H. Parving
Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study
BMJ, March 15, 1997; 314(7083): 783 - 783.
[Abstract] [Full Text]

Home page
 StrokeHome page
H. Miettinen, S. M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso
Proteinuria Predicts Stroke and Other Atherosclerotic Vascular Disease Events in Nondiabetic and Non–Insulin-Dependent Diabetic Subjects
Stroke, November 1, 1996; 27(11): 2033 - 2039.
[Abstract] [Full Text]

Home page
 BMJHome page
P. Rossing, P. Hougaard, K. Borch-Johnsen, and H.-H. Parving
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study
BMJ, September 28, 1996; 313(7060): 779 - 784.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1995 by the American Diabetes Association.